Clin2
NCT07710560Possibly a fitNot yet recruiting

Study on interaction between KL0011034 and alfentanil for chronic pain

Chronic Pain

Part of Pain clinical trials.

This trial tests how a new pain medication, KL0011034, interacts with another drug called alfentanil in people with moderate-to-severe chronic pain that is not caused by cancer. It helps understand if the drugs can be given together safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
27 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Must be between 18 and 55 years old
  • Have moderate-to-severe chronic pain (not from cancer) with a pain score of 4 or more
  • Weigh at least 50 kg for men or 45 kg for women, with a body mass index between 19 and 26
  • Be in generally good health based on medical checks
  • Not have certain medical conditions like asthma, sleep apnea, or history of anesthesia problems
  • Avoid taking certain medications, caffeine, alcohol, or smoking heavily for a period before the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07751094Not yet recruiting· Phase 1
Drug interaction study for chronic pain

This study tests how two pain medications interact when given together. It is for adults with chronic pain (not from cancer) and may help doctors understand how to combine these drugs safely.

NCT07474545Recruiting· Phase 1
Safety study of KL0011034 injection in healthy volunteers

This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.

Changsha, Hunan
NCT07491146Recruiting· Phase 2
Study of HSK55718 for pain after abdominal surgery

This trial tests a new medicine, HSK55718, to see if it safely reduces pain after planned abdominal surgery. It is for adults who have moderate or severe pain after surgery and are otherwise in good health.

Changsha, Hunan
NCT07311369Recruiting· Phase 2
Testing a new pain tablet after abdominal surgery

This trial tests a new pain tablet (HL-1186) for people having abdominal surgery. It aims to see if the tablet is safe and works well to manage pain after the operation.

Changsha, Hunan
NCT06563297Not yet recruiting· Phase 4
Finding the best dose of alfentanil for skull pin fixation

This study tests different doses of a pain medicine called alfentanil to find the best dose for making patients comfortable during the placement of skull pins for brain surgery. It may help improve pain control during the procedure.

Kaohsiung City
NCT07761312Not yet recruiting· Phase 4
Comparing two pain medicines for surgery recovery

This study compares two fast-acting pain medicines given during surgery to see which one provides better anesthesia and recovery. It may help if you are having a non-emergency surgery that is expected to last 1 to 4 hours and you are generally healthy.

Hear when a new Chronic pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.